Targeting FGFR2 May Prevent or Delay Some KRAS-mutated Pancreatic Cancers
April 02, 2025
April 02, 2025
PHILADELPHIA, Pennsylvania, April 2 [Category: Medical] -- The American Association for Cancer Research posted the following news release:
* * *
Targeting FGFR2 May Prevent or Delay Some KRAS-mutated Pancreatic Cancers
The preclinical study has implications for pancreatic cancer interception efforts
PHILADELPHIA - Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had higher-than-no . . .
* * *
Targeting FGFR2 May Prevent or Delay Some KRAS-mutated Pancreatic Cancers
The preclinical study has implications for pancreatic cancer interception efforts
PHILADELPHIA - Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had higher-than-no . . .